Precision BioSciences to Present at the Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Precision BioSciences, a clinical-stage biotechnology company (DTIL), announced that Matt Kane and Derek Jantz will present at the 39th Annual J.P. Morgan Healthcare Conference from January 11-14, 2021. The company's presentation is scheduled for January 13, 2021, from 2:00 - 2:40 p.m. ET. A live webcast of the event will be available on their website, with an archive accessible for 30 days post-presentation. Precision BioSciences is dedicated to advancing life through its ARCUS® genome editing platform, focusing on CAR T immunotherapy and gene correction therapies.

DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced that Matt Kane, Co-founder and Chief Executive Officer and Derek Jantz, Ph.D., Co-Founder and Chief Scientific Officer, will present at the 39^th Annual J.P. Morgan Healthcare Conference taking place virtually from January 11-14, 2021.

Details for the company presentation are as follows:

39^th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 13, 2021
Time: 2:00 - 2:40 p.m. ET

A live webcast of the presentation will be accessible on the Company’s website, www.precisionbiosciences.com, in the Investors & Media section under Events and Presentations. An archived replay of the webcasts will be available for approximately 30 days following the presentations.

About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.

Investor Contact:
Alex Kelly
Interim Chief Financial Officer
Alex.Kelly@precisionbiosciences.com

Media Contact:
Maurissa Messier
Senior Director, Corporate Communications
Maurissa.Messier@precisionbiosciences.com

FAQ

When will Precision BioSciences present at the J.P. Morgan Healthcare Conference 2021?

Precision BioSciences will present on January 13, 2021, from 2:00 - 2:40 p.m. ET.

Where can I watch the Precision BioSciences presentation at the J.P. Morgan Conference?

The presentation will be accessible via a live webcast on the Precision BioSciences website under the Investors & Media section.

What is the focus of Precision BioSciences' ARCUS® platform?

The ARCUS® platform is designed for genome editing, with applications in CAR T immunotherapy and gene correction therapies.

Who are the key speakers from Precision BioSciences at the conference?

The key speakers are Matt Kane, Co-founder and CEO, and Derek Jantz, Ph.D., Co-founder and Chief Scientific Officer.

How long will the recorded presentation be available after the live event?

The archived replay of the presentation will be available for approximately 30 days following the event.